The evolving landscape of ophthalmic clinical trials

The ophthalmic clinical trials landscape is advancing rapidly, with gene therapies, novel biologics, and cutting-edge delivery systems transforming care. But with innovation comes complexity.

In an article with Ophthalmology Times, co-authors Yesha Raval and Lejla Vajzovic, MD, FASRS explore how the clinical trial ecosystem must evolve to meet growing demands, workforce shortages, and regulatory pressures by:

– Strengthening site infrastructure and workforce readiness

– Leveraging the operational benefits of SMOs

– Supporting non-SMO sites to ensure diversity and reach

– Engaging more clinicians in research

Our Visionary Insights newsletter is published once a month and has thousands of subscribers. To stay in touch, subscribe today.